Reports in the state that researchers from Sichov University have successfully completed the clinical trial phase of the vaccine • Principal Investigator: "The vaccine has been proven safe"

• Illustration

  Photo: 

  Reuters

Researchers from the University of Sichov in Russia say they have successfully completed the clinical trial of the vaccine in Corona. That's how the first official Russian news agency Tass posted this evening (Sunday). However, it seems that they have not yet reached the third stage, where a number of larger vaccines are expected to be tested.

The head of the trial at the University of Sichov, Elena Smolarchuk, told the news agency: "The trial is complete and the vaccine has been proven safe. Volunteers will be released on July 15 and 20 and will remain under medical supervision even after discharge."

More on:

"By 2021 there will be at least one vaccine for Corona"

Optimism at the Biological Institute: Positive results for the Corona vaccine

Will a new Pfizer vaccine beat the Corona?

The first phase of vaccine research at Sachanov University began on June 18 when a group of 18 volunteers were vaccinated. The second group of 20 volunteers was vaccinated on June 23. These steps have been very successful in their claim. In the third stage, they are expected to test a larger number of people.